uniQure NV (QURE)
4.60
-0.09
(-1.92%)
USD |
NASDAQ |
Jun 18, 12:09
uniQure Cash from Investing (Quarterly): 63.98M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 63.98M |
| December 31, 2023 | 59.56M |
| September 30, 2023 | -314.07M |
| June 30, 2023 | 45.83M |
| March 31, 2023 | 2.988M |
| December 31, 2022 | -168.21M |
| September 30, 2022 | -5.063M |
| June 30, 2022 | -4.579M |
| March 31, 2022 | -4.88M |
| December 31, 2021 | -3.553M |
| September 30, 2021 | -57.64M |
| June 30, 2021 | -2.315M |
| March 31, 2021 | -3.876M |
| December 31, 2020 | -2.695M |
| September 30, 2020 | -2.183M |
| June 30, 2020 | -1.716M |
| March 31, 2020 | -2.89M |
| December 31, 2019 | -1.963M |
| September 30, 2019 | -2.256M |
| June 30, 2019 | -1.198M |
| March 31, 2019 | -1.23M |
| December 31, 2018 | -0.742M |
| September 30, 2018 | -0.861M |
| Date | Value |
|---|---|
| June 30, 2018 | -1.994M |
| March 31, 2018 | -0.648M |
| December 31, 2017 | -1.215M |
| September 30, 2017 | -0.96M |
| June 30, 2017 | -1.439M |
| March 31, 2017 | -1.969M |
| December 31, 2016 | -3.624M |
| September 30, 2016 | -9.378M |
| June 30, 2016 | -1.695M |
| March 31, 2016 | -2.475M |
| December 31, 2015 | -1.128M |
| September 30, 2015 | -2.940M |
| June 30, 2015 | -1.780M |
| March 31, 2015 | -2.173M |
| December 31, 2014 | -2.546M |
| September 30, 2014 | -5.46M |
| June 30, 2014 | -11.64M |
| March 31, 2014 | -4.299M |
| December 31, 2013 | -2.633M |
| September 30, 2013 | -3.597M |
| June 30, 2013 | -1.794M |
| March 31, 2013 | -0.2215M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-314.07M
Minimum
Sep 2023
63.98M
Maximum
Mar 2024
-20.34M
Average
-2.505M
Median
Cash from Investing (Quarterly) Benchmarks
| ProQR Therapeutics NV | -19.26M |
| Merus NV | -12.08M |
| argenx SE | -- |
| Pharming Group | 0.664M |
| Pharvaris NV | -0.0334M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -60.58M |
| Free Cash Flow | -135.36M |
| Free Cash Flow Per Share (Quarterly) | -1.300 |
| Free Cash Flow to Equity (Quarterly) | -63.29M |
| Free Cash Flow to Firm (Quarterly) | -53.23M |
| Free Cash Flow Yield | -61.42% |